Table 2

Results

Week
Measurement
Results (TP ng/ml) (mean +/- SD; 95% CI; outliers)

1
1
299.24 ± 35.09; 95% CI 199.09 – 258.58;
283.42; 169.49

2
182.97 ± 56.18; 95% CI 136.00 – 229.93;
240.39; 93.80

3
246.77 ± 70.14; 95% CI 188.13 – 305.41;
350.41; 173.99

4
155.20 ± 72.11; 95% CI 94.92 – 215.49;
242.42; 49.57

5
170.66 ± 47.63; 95% CI 130.84 – 210.47;
232.71; 115.57

6
187.55 ± 67.24; 95% CI 131.33 – 243.76;
295.48; 79.59

7
200.79 ± 105.45; 95% CI 112.64 – 288.95;
369.96; 17.24

8
196.36 ± 139.83; 95% CI 79.46 – 313.27;
431.39; 4.74
6
1
233.98 ± 52.29; 95% CI 190.26 – 277.70;
297.52; 125.95

2
177.54 ± 76.06; 95% CI 113.95 – 241.13;
258.41; 50.44

3
179.14 ± 76.68; 95% CI 115.03 – 243.24;
273.87; 43.42

4
110.93 ± 66.80; 95% CI 55.08 – 166.77;
187.07; 20.76

5
183.81 ± 52.89; 95% CI 139.59 – 228.02;
228.32; 60.86

6
185.02 ± 70.87; 95% CI 125.77 – 244.27;
251.34; 43.74

7
232.50 ± 126.58; 95% CI 126.67 – 338.32;
371.45; 6.62

8
215.03 ± 90.78; 95% CI 139.13 – 290.92;
297.99; 7.56

Bartsch et al. BMC Clinical Pharmacology 2007 7:7   doi:10.1186/1472-6904-7-7